Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian share markets open firm
Tue, 14 May 09:30 am

Asian stock markets have opened the day on a mixed note with China (down 1.6%) and Hong Kong (down 0.1%) leading the losses. However, markets in South Korea (up 0.8%) and Singapore (up 0.3%) are trading firm. The Indian share markets indices have opened the day on a firm note. The sectoral indices have opened mixed with stocks in healthcare and technology leading the gains. However, the stocks in auto and consumer durables space are leading the losses.

The Sensex today is up by around 44 points (0.2%), while the NSE-Nifty is up by around 13 points (0.2%). Mid and small cap stocks are also trading in the green with the BSE Mid Cap and BSE Small Cap indices up by around 0.3% and 0.2% respectively. The rupee is trading at Rs 54.77 to the US dollar.

Pharma stocks have opened the day mainly in green with Indoco Remedies Ltd and Glenmark Pharma Ltd leading the gains. As per a leading financial daily, leading drug maker Ranbaxy Laboratories Ltd has pleaded guilty to felony charges related to drug safety. It has agreed to pay US$ 500 m in civil and criminal fines. This is under the settlement agreement with the U.S. Department of Justice. It was Mr. Dinesh Thakur, former Ranbaxy director and global head of research information & portfolio management who had uncovered the unsafe practices and violations at Ranbaxy. He had notified the management of these issues. However, the management's failure to solve problems led Mr. Thakur to alert healthcare authorities. As per the Justice Department, Mr. Thakur is entitled to US $48.6 m as the whistleblower in the case.

Steel stocks have opened the day on a mainly in the red with Tata Steel and Tayo Rolls Ltd leading the losses. As per a leading financial daily, Tata Steel will book a US$ 1.6 bn non cash impairment charge for the financial year that ended March 31, 2013. The impairment charge is for the loss of value of Tata Steel Europe (TSE), formerly Corus, and other overseas assets in Thailand and South Africa. The write-down is 63% higher than Tata Steel's entire net profit for the previous fiscal of 2012 (FY12). It is mainly on account of weak economic and market conditions in Europe that happens to be its main market. The steel demand in Europe has fallen by 8% year on year in 2012-13. As per the management, the weak scenario is likely to continue over the near and medium term. It has led to the downward revision of cash flow expectations underlying the valuation of the European business.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets open firm". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.